||Dr. Asher Hasan|
Founder and Chief Executive Officer of NAYA JEEVAN
||“Scaling the Emerging World's First HMO for the Poor: What the Obama Administration can learn from South Asia”|
||6:00PM – 8:00PM|
||Scaling the Emerging World’s First "HMO for the Poor"|
Dr. Asher Hasan is the Founder and Chief Executive Officer of NAYA JEEVAN, a not-for-profit social enterprise dedicated to providing socio-economically disadvantaged families throughout the emerging world with affordable access to quality, catastrophic healthcare.
Dr. Hasan was recently selected as a Draper Richards Social Entrepreneur Fellow for 2009-2011 that is accompanied with a $300,000 award and is an invited member of the Clinton Global Initiative. In addition, NAYA JEEVAN is also the recipient of a $75,000 1st prize in the 2008 NYU Social Entrepreneurship Business Plan competition.
Prior to launching NAYA JEEVAN, Dr. Hasan served in the capacity of Senior Director and Head of the US Medical Affairs Obesity team for Amylin Pharmaceuticals, Inc. Prior to relocating to California, Dr. Hasan served as the US Medical Director for sanofi-aventis, based out of their US headquarters in Bridgewater, NJ. During his tenure in New York City, Dr. Hasan also completed a Masters in Business Administration (MBA) from New York University’s Stern School of Business.
After migrating to the US, Dr, Hasan attended Oberlin College where he obtained a bachelor’s degree in neuroscience and biology with an additional concentration in international relations.
Subsequently, Dr. Hasan moved to Harvard Medical School where he worked as a preclinical researcher along with a group of vascular surgeons at Brigham & Women’s Hospital. His research endeavors were focused on evaluating the incidence of restenosis in a rat carotid artery model following balloon angioplasty.
Graduating summa cum laude, Dr. Hasan successfully completed his MD degree from the State University of New York. He then went on to train in General Surgery at Beth Israel Medical Center in New York City.
In addition to his affiliation with the biotech/pharmaceutical industry in the US, Dr. Hasan is an active member of NAASO-The Obesity Society, the American Heart Association and the American Diabetes Association. He also recently (2005-2006) served as a board member of the US National Business Group on Health: Institute on Cost & Effects of Obesity.